Randy Schekman to Leave <em>eLife</em>
Randy Schekman to Leave eLife
The founding editor-in-chief will redirect his focus to a Parkinson’s organization.
Randy Schekman to Leave eLife
Randy Schekman to Leave eLife

The founding editor-in-chief will redirect his focus to a Parkinson’s organization.

The founding editor-in-chief will redirect his focus to a Parkinson’s organization.

journal, disease & medicine, immunology, microbiology
Synthetic Bacteria Help Treat Phenylketonuria in MiceSynthetic Bacteria Help Treat Phenylketonuria in Mice
Synthetic Bacteria Help Treat Phenylketonuria in Mice
Diana Kwon | Aug 17, 2018
The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.
Synthetic Cannabinoid K2 Overdoses Are Rampant. Here&rsquo;s Why.
Synthetic Cannabinoid K2 Overdoses Are Rampant. Here’s Why.
Ashley Yeager | Aug 17, 2018
NIDA pharmacologist Michael Baumann explains how “unscrupulous vendors” hijacked compounds used in neuroscience and turned them into dangerous drugs.
Zika Likes it Warmer than Dengue: Study
Zika Likes it Warmer than Dengue: Study
Anna Azvolinsky | Aug 15, 2018
Climate change may open up new habitats suitable for the virus’s spread.
Reprogrammed M&uuml;ller Glia Restore Vision in Mice
Reprogrammed Müller Glia Restore Vision in Mice
Ashley Yeager | Aug 15, 2018
A double gene-transfer therapy transformed the non-neuronal cells into rod photoreceptors in the retinas of animal models of congenital blindness.
Vaping Damages Immune Cells, Researchers Find
Vaping Damages Immune Cells, Researchers Find
Catherine Offord | Aug 14, 2018
A small, in vitro study concludes that e-cigarette vapor harms macrophages taken from human lung tissue.
Q&amp;A: Anthony Fauci Describes an Experimental Ebola Treatment
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Jury Finds Monsanto&rsquo;s Roundup Responsible for Man&rsquo;s Cancer
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Sukanya Charuchandra | Aug 13, 2018
A San Francisco court levels $289 Million in damages against the pesticide maker.
Image of the Day: Slimy Business
Image of the Day: Slimy Business
Sukanya Charuchandra | Aug 13, 2018
A new study reports finding corn species in Mexico that can trap nitrogen.
First RNAi Therapy Approved by FDA
First RNAi Therapy Approved by FDA
Kerry Grens | Aug 10, 2018
Alnylam’s patisiran interferes with the production of a mutated protein present in people with hereditary transthyretin amyloidosis.